Polycystic ovary syndrome. Polycystic ovary syndrome
Conditions
Interventions
Intervention 1: Intervention Group: 2 tablets of .5 Mg of dexamethasone (Daroupakhsh, Iran). Intervention 2: Control group :
400 micrograms of folic acid tablets (Natur Made / USA).
Treatment - Drugs
Placebo
Intervention Group: 2 tablets of .5 Mg of dexamethasone (Daroupakhsh, Iran)
Control group :
400 micrograms of folic acid tablets (Natur Made / USA)
Sponsors
Vice Chancellor for Research and Technology, Babol University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: PCOs women with infertility duration less than 5 years; Age range 30-20 years. Exclusion criteria: Women with uterine problems such as Uterine fibroids and internal septa; Endometriosis; Women with a history of ovarian or ovarian surgery; The problem of male infertility.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical pregnancy. Timepoint: The detection of fetal heartbeat, two weeks after being tested positive for HCG. Method of measurement: Ultrasound. | — |
Secondary
| Measure | Time frame |
|---|---|
| The number of embryos obtained. Timepoint: On the third day after the oocyte Removal. Method of measurement: Ultrasound.;Number of oocytes. Timepoint: 36-34 h after HCG injection. Method of measurement: Ultrasound.;Gonadotropin dose. Timepoint: The third day of the next menstrual cycle. Method of measurement: Clinical. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNargess Gholizadeh Pasha
Fatemehzahra Fertility & reproductive Health Reseach Center
Outcome results
None listed